A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT05797805 · RECRUITING
Trial details
- NCT number
- NCT05797805
- Sponsor
- Iterion Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-13
- Primary completion
- 2026-05-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.